| Analysis | Metabolite Name | Measured Value | Units | Group |
|---|---|---|---|---|
| HILIC POSITIVE ION MODE | 3-(3-hydroxyphenyl)propionate | 0.0737 | Peak area | Diabetic Neuropathy |
| HILIC POSITIVE ION MODE | 3-(3-hydroxyphenyl)propionate | 0.0737 | Peak area | Diabetic non neuropathy |
| HILIC POSITIVE ION MODE | 3-(3-hydroxyphenyl)propionate | 0.1179 | Peak area | Diabetic non neuropathy |
| HILIC POSITIVE ION MODE | 3-(3-hydroxyphenyl)propionate | 0.1719 | Peak area | Diabetic non neuropathy |
| HILIC POSITIVE ION MODE | 3-(3-hydroxyphenyl)propionate | 0.1903 | Peak area | Diabetic Neuropathy |
| HILIC POSITIVE ION MODE | 3-(3-hydroxyphenyl)propionate | 0.2219 | Peak area | Diabetic Neuropathy |
| HILIC POSITIVE ION MODE | 3-(3-hydroxyphenyl)propionate | 0.2526 | Peak area | Diabetic non neuropathy |
| HILIC POSITIVE ION MODE | 3-(3-hydroxyphenyl)propionate | 0.2601 | Peak area | Normal |
| HILIC POSITIVE ION MODE | 3-(3-hydroxyphenyl)propionate | 0.2766 | Peak area | Diabetic Neuropathy |
| HILIC POSITIVE ION MODE | 3-(3-hydroxyphenyl)propionate | 0.2858 | Peak area | Diabetic Neuropathy |
| HILIC POSITIVE ION MODE | 3-(3-hydroxyphenyl)propionate | 0.2880 | Peak area | Diabetic Neuropathy |
| HILIC POSITIVE ION MODE | 3-(3-hydroxyphenyl)propionate | 0.3117 | Peak area | Normal |
| HILIC POSITIVE ION MODE | 3-(3-hydroxyphenyl)propionate | 0.3421 | Peak area | Diabetic Neuropathy |
| HILIC POSITIVE ION MODE | 3-(3-hydroxyphenyl)propionate | 0.3952 | Peak area | Normal |
| HILIC POSITIVE ION MODE | 3-(3-hydroxyphenyl)propionate | 0.4032 | Peak area | Diabetic Neuropathy |
| HILIC POSITIVE ION MODE | 3-(3-hydroxyphenyl)propionate | 0.4317 | Peak area | Diabetic Neuropathy |
| HILIC POSITIVE ION MODE | 3-(3-hydroxyphenyl)propionate | 0.4643 | Peak area | Diabetic non neuropathy |
| HILIC POSITIVE ION MODE | 3-(3-hydroxyphenyl)propionate | 0.4685 | Peak area | Diabetic non neuropathy |
| HILIC POSITIVE ION MODE | 3-(3-hydroxyphenyl)propionate | 0.4722 | Peak area | Normal |
| HILIC POSITIVE ION MODE | 3-(3-hydroxyphenyl)propionate | 0.4760 | Peak area | Diabetic non neuropathy |
| HILIC POSITIVE ION MODE | 3-(3-hydroxyphenyl)propionate | 0.4908 | Peak area | Diabetic non neuropathy |
| HILIC POSITIVE ION MODE | 3-(3-hydroxyphenyl)propionate | 0.5334 | Peak area | Diabetic non neuropathy |
| HILIC POSITIVE ION MODE | 3-(3-hydroxyphenyl)propionate | 0.5433 | Peak area | Diabetic non neuropathy |
| HILIC POSITIVE ION MODE | 3-(3-hydroxyphenyl)propionate | 0.5675 | Peak area | Normal |
| HILIC POSITIVE ION MODE | 3-(3-hydroxyphenyl)propionate | 0.5686 | Peak area | Diabetic Neuropathy |
| HILIC POSITIVE ION MODE | 3-(3-hydroxyphenyl)propionate | 0.6013 | Peak area | Diabetic Neuropathy |
| HILIC POSITIVE ION MODE | 3-(3-hydroxyphenyl)propionate | 0.7199 | Peak area | Diabetic non neuropathy |
| HILIC POSITIVE ION MODE | 3-(3-hydroxyphenyl)propionate | 0.7224 | Peak area | Diabetic Neuropathy |
| HILIC POSITIVE ION MODE | 3-(3-hydroxyphenyl)propionate | 0.7412 | Peak area | Diabetic Neuropathy |
| HILIC POSITIVE ION MODE | 3-(3-hydroxyphenyl)propionate | 0.7460 | Peak area | Diabetic non neuropathy |
| HILIC POSITIVE ION MODE | 3-(3-hydroxyphenyl)propionate | 0.7553 | Peak area | Diabetic non neuropathy |
| HILIC POSITIVE ION MODE | 3-(3-hydroxyphenyl)propionate | 0.7715 | Peak area | Normal |
| HILIC POSITIVE ION MODE | 3-(3-hydroxyphenyl)propionate | 0.7866 | Peak area | Diabetic Neuropathy |
| HILIC POSITIVE ION MODE | 3-(3-hydroxyphenyl)propionate | 0.8528 | Peak area | Diabetic Neuropathy |
| HILIC POSITIVE ION MODE | 3-(3-hydroxyphenyl)propionate | 0.8568 | Peak area | Diabetic Neuropathy |
| HILIC POSITIVE ION MODE | 3-(3-hydroxyphenyl)propionate | 0.8656 | Peak area | Diabetic non neuropathy |
| HILIC POSITIVE ION MODE | 3-(3-hydroxyphenyl)propionate | 0.8919 | Peak area | Diabetic Neuropathy |
| HILIC POSITIVE ION MODE | 3-(3-hydroxyphenyl)propionate | 0.9463 | Peak area | Diabetic Neuropathy |
| HILIC POSITIVE ION MODE | 3-(3-hydroxyphenyl)propionate | 1.0537 | Peak area | Diabetic non neuropathy |
| HILIC POSITIVE ION MODE | 3-(3-hydroxyphenyl)propionate | 1.1133 | Peak area | Diabetic non neuropathy |
| HILIC POSITIVE ION MODE | 3-(3-hydroxyphenyl)propionate | 1.1228 | Peak area | Diabetic Neuropathy |
| HILIC POSITIVE ION MODE | 3-(3-hydroxyphenyl)propionate | 1.3001 | Peak area | Diabetic Neuropathy |
| HILIC POSITIVE ION MODE | 3-(3-hydroxyphenyl)propionate | 1.3187 | Peak area | Diabetic non neuropathy |
| HILIC POSITIVE ION MODE | 3-(3-hydroxyphenyl)propionate | 1.3580 | Peak area | Diabetic non neuropathy |
| HILIC POSITIVE ION MODE | 3-(3-hydroxyphenyl)propionate | 1.4332 | Peak area | Diabetic Neuropathy |
| HILIC POSITIVE ION MODE | 3-(3-hydroxyphenyl)propionate | 1.5547 | Peak area | Diabetic Neuropathy |
| HILIC POSITIVE ION MODE | 3-(3-hydroxyphenyl)propionate | 1.6138 | Peak area | Diabetic non neuropathy |
| HILIC POSITIVE ION MODE | 3-(3-hydroxyphenyl)propionate | 1.9236 | Peak area | Diabetic Neuropathy |
| HILIC POSITIVE ION MODE | 3-(3-hydroxyphenyl)propionate | 2.0144 | Peak area | Diabetic non neuropathy |
| HILIC POSITIVE ION MODE | 3-(3-hydroxyphenyl)propionate | 2.0772 | Peak area | Diabetic non neuropathy |
| HILIC POSITIVE ION MODE | 3-(3-hydroxyphenyl)propionate | 2.0796 | Peak area | Normal |
| HILIC POSITIVE ION MODE | 3-(3-hydroxyphenyl)propionate | 2.1344 | Peak area | Diabetic Neuropathy |
| HILIC POSITIVE ION MODE | 3-(3-hydroxyphenyl)propionate | 2.2232 | Peak area | Diabetic non neuropathy |
| HILIC POSITIVE ION MODE | 3-(3-hydroxyphenyl)propionate | 2.4052 | Peak area | Diabetic non neuropathy |
| HILIC POSITIVE ION MODE | 3-(3-hydroxyphenyl)propionate | 2.4085 | Peak area | Diabetic non neuropathy |
| HILIC POSITIVE ION MODE | 3-(3-hydroxyphenyl)propionate | 2.5167 | Peak area | Diabetic non neuropathy |
| HILIC POSITIVE ION MODE | 3-(3-hydroxyphenyl)propionate | 2.5868 | Peak area | Diabetic non neuropathy |
| HILIC POSITIVE ION MODE | 3-(3-hydroxyphenyl)propionate | 2.7479 | Peak area | Normal |
| HILIC POSITIVE ION MODE | 3-(3-hydroxyphenyl)propionate | 2.7985 | Peak area | Diabetic non neuropathy |
| HILIC POSITIVE ION MODE | 3-(3-hydroxyphenyl)propionate | 2.8247 | Peak area | Diabetic non neuropathy |
| HILIC POSITIVE ION MODE | 3-(3-hydroxyphenyl)propionate | 3.0537 | Peak area | Diabetic non neuropathy |
| HILIC POSITIVE ION MODE | 3-(3-hydroxyphenyl)propionate | 3.0857 | Peak area | Diabetic non neuropathy |
| HILIC POSITIVE ION MODE | 3-(3-hydroxyphenyl)propionate | 3.0896 | Peak area | Diabetic Neuropathy |
| HILIC POSITIVE ION MODE | 3-(3-hydroxyphenyl)propionate | 3.1681 | Peak area | Diabetic Neuropathy |
| HILIC POSITIVE ION MODE | 3-(3-hydroxyphenyl)propionate | 3.7443 | Peak area | Normal |
| HILIC POSITIVE ION MODE | 3-(3-hydroxyphenyl)propionate | 4.4645 | Peak area | Diabetic Neuropathy |
| HILIC POSITIVE ION MODE | 3-(3-hydroxyphenyl)propionate | 4.8943 | Peak area | Diabetic non neuropathy |
| HILIC POSITIVE ION MODE | 3-(3-hydroxyphenyl)propionate | 5.2935 | Peak area | Diabetic Neuropathy |
| HILIC POSITIVE ION MODE | 3-(3-hydroxyphenyl)propionate | 5.7677 | Peak area | Diabetic Neuropathy |
| HILIC POSITIVE ION MODE | 3-(3-hydroxyphenyl)propionate | 6.1132 | Peak area | Diabetic Neuropathy |
| HILIC POSITIVE ION MODE | 3-(3-hydroxyphenyl)propionate | 6.5147 | Peak area | Diabetic non neuropathy |
| HILIC POSITIVE ION MODE | 3-(3-hydroxyphenyl)propionate | 8.6231 | Peak area | Diabetic non neuropathy |
| HILIC POSITIVE ION MODE | 3-(3-hydroxyphenyl)propionate | 8.7906 | Peak area | Diabetic non neuropathy |
| HILIC POSITIVE ION MODE | 3-(3-hydroxyphenyl)propionate | 9.4648 | Peak area | Diabetic non neuropathy |
| HILIC POSITIVE ION MODE | 3-(3-hydroxyphenyl)propionate | 10.7408 | Peak area | Diabetic Neuropathy |
- UCSD Metabolomics Workbench, a resource sponsored by the Common Fund of the National Institutes of Health
|